Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Induces DNA strand breakage.
Derivative of aloe-emodin, anthraquinone found ...
c-Raf inhibitor.
PORCN inhibitor.
Mycotoxin produced by species of Aspergillus; D...
Antimicrobial found in essential oils from plan...
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Aromatic retinoid; RAR, RXR agonist.
D2/3 agonist.
Phenolic phytoalexin found in soy, grapes, and ...
Akt inhibitor.
Kynurenine 3-hydroxylase inhibitor.
Carbapenem β-lactam; penicillin binding protei...
Bisphosphonate.
Polyketide; DNMT 1 inhibitor, RNA synthesis inh...
Bisphosphonate; squalene synthase inhibitor.
JAK2 inhibitor.
TTK/CLK2 inhibitor.
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Triazole; demethylation inhibitor.